PMID: Nutrition. 2015 Jul 2. Epub 2015 Jul 2. PMID: 26412579 Abstract Title: Green tea and liver cancer risk: A meta-analysis of prospective cohort studies in Asian populations. Abstract: OBJECTIVES: The aim of this meta-analysis was to investigate whether an association existed between green tea consumption and the risk for liver cancer in prospective cohort studies in Asian populations.METHODS: Relevant studies were identified by searching PubMed, EMBASE, ISI Web of Science, and the Chinese Bio-medicine Database published before April 2015. Study-specific risk estimates for the highest versus non- or lowest and increment of daily cup of green tea consumption levels were combined based on fixed- or random-effects models. STATA 11.0 (Stata Corporation, College Station, TX, USA) software was used for statistical analysis.RESULTS: Nine prospective cohort articles involving 465,274 participants and 3694 cases of liver cancer from China, Japan, and Singapore were included. The summary relative risk (RR) indicated a significant association between the highest green tea consumption and reduced risk for liver cancer (summary RR, 0.88; 95% confidence interval [CI], 0.81-0.97). However, no statistically significant association was observed when analyzing daily consumption of one cup (summary RR, 0.97; 95% CI, 0.95-1.00). When stratified by sex, the protective effect of green tea consumption on risk for liver cancer was observed only in the group of women (summary RR, 0.78; 95% CI, 0.64-0.96), but not in men (summary RR, 0.89; 95% CI, 0.79-1.00).CONCLUSIONS: The present analysis indicated the preventive effects of green tea intake on the risk for liver cancer in female Asian populations. However, additional studies are needed to make a convincing case for this association.
via Health News Spirulina http://www.greenmedinfo.com/article/present-analysis-indicated-preventive-effects-green-tea-intake-risk-liver
via Health News Spirulina http://www.greenmedinfo.com/article/present-analysis-indicated-preventive-effects-green-tea-intake-risk-liver